Physician profile
Eric Pedersen
NPI 1477120160
$1,097.77
in general payments reported to CMS, 2019-2025
16 companies · $19.38 in 2025
The $19.38 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.02 · 2022: $224 · 2023: $565 · 2024: $272 · 2025: $19.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $441.04 | 2022-2024 | Epclusa |
| Abbvie INC. | $134.68 | 2022-2024 | |
| Exact Sciences Corporation | $82.88 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $68.70 | 2022-2024 | |
| Neurocrine Biosciences, INC. | $55.36 | 2023-2024 | Ingrezza |
| Janssen Pharmaceuticals, INC | $48.47 | 2023-2024 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.76 | 2023-2024 | Caplyta |
| Dexcom, INC. | $38.79 | 2023-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $37.59 | 2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Novo Nordisk INC | $30.25 | 2023-2024 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $29.34 | 2023-2024 | Rexulti, Abilify Maintena |
| Ultragenyx Pharmaceutical INC. | $19.78 | 2023 | |
| Lilly USA, LLC | $17.77 | 2023 | Mounjaro |
| Endo Pharmaceuticals INC. | $17.02 | 2021 | |
| Sanofi Pasteur INC. | $15.57 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.77 | 2024 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pedersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.